Soraniog, Corazon M.
HRN: 26-02-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/09/2024
10/16/2024
IVT
4.5g
Q6h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes